A culture medium and fermentation method for improving the fermentation production of Schizochytrium with high DHA content and high sn-2DHA ratio

By using Brewer yeast wall breaking liquid as a nitrogen source in fermentation of cleavage pyrphyllum and using calcium carbonate and sodium carbonate to adjust the pH value of the fermentation liquid, the problem of increasing DHA content and sn-2DHA proportion was solved, and production costs were reduced, thus achieving Efficient DHA bioavailability.

CN117467714BActive Publication Date: 2024-11-22XIAMEN HUISON BIOTECH CO LTD

Patent Information

Application Number
CN202311411521.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-10-27
Publication Date
2024-11-22
Estimated Expiration
2043-10-27

AI Technical Summary

Technical Problem

The prior art is difficult to effectively increase the high DHA content and high sn-2DHA fermentation of cytylphyllum, and the traditional industrial production of algae oil is high cost, and the yeast impregnation powder is expensive and the conversion efficiency is low.

Method used

Brewer yeast wall breaking liquid is used as the nitrogen source, and the pH value of the fermentation liquid is adjusted through carbonates such as calcium carbonate and sodium carbonate. Combined with optimized fermentation process steps and culture medium formula, the dry weight, total oil and DHA content of the fermentation liquid is increased. and sn-2DHA proportion.

Benefits of technology

The dry weight, total oil, DHA yield and sn-2DHA ratio of the fermentation broth are significantly increased, the production cost is reduced, and technical solutions to solve the bioavailability of efficient DHA are provided.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention belongs to the field of biotechnology. The present invention provides a culture medium for improving the production of high DHA content and high sn-2DHA ratio by Schizochytrium fermentation, characterized in that the culture medium contains brewer's yeast cell wall breaking liquid. The present invention uses a culture medium containing brewer's yeast cell wall breaking liquid to solve the problem of how to increase the dry weight, total fat, DHA content and sn-2DHA ratio of the fermentation liquid.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biotechnology, and in particular to a culture medium and a fermentation method for improving the production of high DHA content and high sn-2DHA ratio by fermentation of Schizochytrium. Background Art

[0002] Unsaturated fatty acids are essential fatty acids for the human body. Their physiological function is to maintain the relative fluidity of cell membranes to ensure the normal physiological activities of cells. According to the position and function of double bonds, polyunsaturated fatty acids can be divided into ω-6 series and ω-3 series. Linoleic acid and arachidonic acid belong to the ω-6 series, while linolenic acid, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) belong to the ω-3 series. Docosahexaenoic acid (DHA), also known as "brain gold", is an indispensable substance for the normal functioning of the human cardiovascular, nervous and visual systems. DHA is present in high levels in the human cerebral cortex, accounting for about 24.30-36.60% of the brain's gray matter phospholipids and about 50% of the retina of the eye. It is crucial to the intellectual and visual development of infants and young children.

[0003] Based on the role of DHA, some products containing DHA have appeared on the market, such as DHA formula milk powder, nutritional milk powder for pregnant women, fish oil capsules, etc., which are mainly dedicated to promoting the intellectual development of infants and young children, supplementing nutrition for pregnant women, and enhancing immunity of the middle-aged and elderly people. According to the differences in lipid structure, DHA can be divided into glyceride type (TAG), ethyl ester type (EE), free type (FFA), etc. Relevant studies have shown that the differences in the configuration and distribution of DHA will affect its bioavailability. Although the content of ethyl ester DHA is higher than that of triglyceride DHA, its bioavailability in the body is far less than that of glyceride and free DHA. After the human body ingests DHA, sn-1,3 specific lipase can hydrolyze TAG into sn-2 monoglyceride and free fatty acids, among which sn-2 monoglyceride can be absorbed through the small intestinal mucosa, and then converted into DAG and phospholipids in the body to exert its physiological function, while the rate of pancreatic lipase hydrolyzing EE-DHA is 10-15 times lower than that of TAG-DHA. Therefore, the distribution of DHA on the glycerol skeleton affects the efficiency of its digestion and absorption and the conversion of its functions. Narcisa et al. fed mice with fish oil, fish oil ethyl ester and sn-2DHA lipids respectively. The results showed that the levels of n-3 fatty acids in the brain, liver and blood of mice fed with sn-2DHA lipids were significantly higher than those of other groups, and the levels of cholesterol, low-density lipoprotein and TGA in mice were also significantly reduced. In another study, it was found that the level of DHA in the brain of mice fed with sn-2DHA supplements, such as phosphatidylserine, was higher than that of mice fed with milk. Human milk is the main nutrient for the growth and development of infants and young children. DHA in milk fat mainly exists in the form of triglycerides, of which more than 50% of DHA is distributed in the sn-2 position. As the milk matures, the DHA content in milk fat will decrease relatively, but the proportion of sn-2 DHA will gradually increase. It can be seen that supplementing DHA during lactation, especially sn-2DHA, is particularly important for the development of the nervous system of infants and young children. The main sources of commercial DHA are deep-sea fish oil and algae oil. The DHA content of natural fish oil is generally around 20-30%, and the sn-2DHA content of natural fish oil extracted from tuna, sardines, anchovies, etc. can be between 44.79% and 72.99%. However, deep-sea fish resources are limited, the DHA content in fish oil is relatively low, and there are problems such as high purification cost, unpleasant fishy smell, heavy metals, and unstable production. Therefore, DHA from fish oil cannot meet the growing market demand.

[0004] The production of DHA by fermentation of marine microalgae has always been a hot topic of research. As the dominant strain for commercial production of DHA, Schizochytrium has the characteristics of short fermentation cycle, no influence from the external environment, and high DHA yield, so it is a sustainable resource to replace fish oil. The DHA content of Schizochytrium oil is generally between 40-60%. Studies have shown that the proportion of sn-2DHA in algae oil is generally between 31.66% and 42.09% of glyceride DHA, which is lower than the proportion of sn-2-DHA in natural fish oil. In addition, as heterotrophic microorganisms, yeast extract and yeast paste are good organic nitrogen sources for the fermentation of DHA by Schizochytrium. Traditional industrial production of algae oil DHA mainly uses yeast extract, but yeast extract is relatively expensive, and the conversion is inefficient. In addition, a large amount of energy needs to be input during the production process, and the equipment investment and maintenance costs are expensive, making the current production cost of algae oil DHA very high. Therefore, by utilizing superior bacterial strains and improving the fermentation process, we can obtain a fermentation technology process that produces high DHA content and a high sn-2DHA ratio, so as to improve the bioavailability of DHA and give full play to the physiological functions of DHA. Summary of the invention

[0005] In order to solve the above technical problems, the present invention provides a culture medium for improving the production of high DHA content and high sn-2DHA ratio by Schizochytrium schizochytrium fermentation, characterized in that the culture medium contains brewer's yeast cell wall breaking liquid. In the technical solution of the present invention, the brewer's yeast cell wall breaking liquid is not only provided to Schizochytrium schizochytrium as a nitrogen source, but also can solve the problem of how to increase the dry weight, total fat, DHA content and sn-2DHA ratio of the fermentation liquid; at the same time, if the method for adjusting the pH value of the fermentation liquid described in the present invention is used, carbonates such as calcium carbonate and sodium carbonate are used as buffers to adjust the pH value of the fermentation liquid, and better technical effects can be obtained.

[0006] In one aspect, the present invention provides a culture medium for improving the production of high DHA content and high sn-2DHA ratio by fermentation of Schizochytrium sp., wherein the culture medium contains brewer's yeast cell wall-breaking liquid.

[0007] In some embodiments, the preparation method of brewer's yeast cell wall-breaking liquid includes: brewer's yeast and water, with a solid-liquid volume ratio of 1:10, adjusting the pH value to 5.5-6.5, and hydrolyzing with protease and β-glucanase at 50-60°C for 18-24h; after enzymolysis, heating and inactivating the enzyme to obtain brewer's yeast cell wall-breaking liquid.

[0008] In some embodiments, the preparation method of brewer's yeast cell wall-breaking liquid includes: mixing fresh brewer's yeast with water in a solid-liquid volume ratio of 1:10, adjusting the pH value to 6, and hydrolyzing with protease and β-glucanase at 55°C for 18-24 hours; after enzymolysis, heating and inactivating the enzyme to obtain brewer's yeast cell wall-breaking liquid.

[0009] In some embodiments of the method for preparing brewer's yeast cell wall-breaking liquid, hydrochloric acid and sodium hydroxide are used to adjust the pH value.

[0010] In some embodiments of the method for preparing brewer's yeast cell wall-breaking liquid, the protease is microbial protease, animal protease, or plant protease.

[0011] In some embodiments of the method for preparing brewer's yeast cell wall-breaking liquid, the protease is neutral protease, alkaline protease, trypsin, papain, or bromelain.

[0012] In some embodiments of the method for preparing brewer's yeast cell wall-breaking liquid, the protease is alkaline protease.

[0013] In some embodiments of the method for preparing brewer's yeast cell wall-breaking liquid, the mass ratio of the protease to the β-glucanase is (8-12):1.

[0014] In some embodiments of the method for preparing brewer's yeast cell wall-breaking liquid, the mass ratio of the protease to the β-glucanase is 10:1.

[0015] In some embodiments, the concentration of the brewer's yeast cell wall-breaking solution is 15-25 g / L.

[0016] In some embodiments, the concentration of the brewer's yeast cell wall-breaking solution is 15-20 g / L.

[0017] In some embodiments, the culture medium contains a pH adjuster.

[0018] In some embodiments, the pH adjuster includes: one or more selected from ammonia water, sodium hydroxide, sodium carbonate, sodium bicarbonate, calcium carbonate, citric acid, malic acid, acetic acid, propionic acid, hydrochloric acid and sulfuric acid.

[0019] In some embodiments, the pH adjuster includes: one or more selected from ammonia water, sodium hydroxide, sodium carbonate, sodium bicarbonate, calcium carbonate, and one or more selected from citric acid, malic acid, acetic acid, propionic acid, hydrochloric acid and sulfuric acid.

[0020] In some embodiments, the pH adjuster includes: one or more selected from ammonia water, sodium carbonate, sodium bicarbonate, calcium carbonate, and one or more selected from citric acid and malic acid.

[0021] In some embodiments, the pH adjuster includes: one or more selected from ammonia water, calcium carbonate, and malic acid.

[0022] In some embodiments, the culture medium further comprises a carbon source, inorganic salts, and vitamins.

[0023] In some embodiments, the carbon source includes: one or more of glucose, corn syrup, glycerol, and sucrose;

[0024] In some embodiments, the carbon source concentration is 50-80 g / L.

[0025] In some embodiments, the carbon source concentration is 60-70 g / L.

[0026] In some embodiments, the inorganic salt includes: one or more combinations of anhydrous sodium sulfate, anhydrous magnesium sulfate, potassium sulfate, potassium dihydrogen phosphate, potassium chloride and anhydrous calcium chloride.

[0027] In some embodiments, anhydrous sodium sulfate 11-19 g / L, anhydrous magnesium sulfate 2.0-6.0 g / L, potassium sulfate 0.5-1.5 g / L, potassium dihydrogen phosphate 0.5-1.5 g / L, potassium chloride 0.3-1 g / L, anhydrous calcium chloride 0.1-0.3 g / L.

[0028] In some embodiments, the vitamins include: vitamin B1, vitamin B5, vitamin B2, vitamin B6 and vitamin B 12 One or more combinations of .

[0029] In some embodiments, the vitamins include: vitamin B1 0.5-2.0 mg / L, vitamin B5 2-6 mg / L, vitamin B2 2-6 mg / L, vitamin B6 0.01-0.05 mg / L, vitamin B 12 0.2~0.6mg / L.

[0030] In some embodiments, the culture medium further comprises a nitrogen source.

[0031] In some embodiments, the nitrogen source is selected from one or more of yeast powder, corn steep liquor powder, and ammonium sulfate.

[0032] In some embodiments, the nitrogen source is selected from: ammonium sulfate.

[0033] In some embodiments, the nitrogen source has a concentration of 1-20 g / L.

[0034] In some embodiments, the nitrogen source is selected from ammonium sulfate, and the concentration of ammonium sulfate is 1.0-3.0 g / L.

[0035] On the other hand, the present invention also provides a fermentation method for improving the production of high DHA content and high sn-2DHA ratio by Schizochytrium fermentation, characterized in that the method comprises the following steps:

[0036] (1) Primary seed tank culture: inoculation amount is 2-5%; pH is controlled at 5.5-6.0, residual sugar is less than 20g / L and inoculated into the secondary seed tank;

[0037] (2) Secondary seed tank culture: inoculation amount is 8-15%; pH is controlled at 5.5-6.0, and residual sugar is less than 20 g / L before inoculation into the fermentation tank;

[0038] (3) Fermentation tank culture: pH is controlled at 5.0-6.5, sugar concentration is controlled at 40-60 g / L before 72 hours; from 72 to 96 hours, sugar concentration is controlled at 10-20 g / L;

[0039] The culture medium used for the fermentation tank culture is the culture medium according to any one of claims 1 to 7.

[0040] In some embodiments, the method comprises the following steps:

[0041] (1) Primary seed tank culture: The Schizochytrium seeds were inoculated into the primary culture medium at an inoculation rate of 2.5%; the initial glucose was 60 g / L, the temperature was controlled at 25°C, the dissolved oxygen was controlled to be greater than 30%, the pH was 5.5-6.0, and the residual sugar was less than 20 g / L and inoculated into the secondary seed tank;

[0042] (2) Secondary seed tank culture: inoculation amount is 10%; initial glucose is 60 g / L, temperature is controlled at 25°C, dissolved oxygen is controlled to be greater than 30%, pH is 5.5-6.0, and residual sugar is less than 20 g / L and inoculated into the fermentation tank;

[0043] (3) Fermentation tank culture: The pH of the fermentation tank culture is controlled at 5.0-6.5, and the dissolved oxygen is controlled at 40%-70% by adjusting the ventilation volume and the rotation speed; the sugar concentration is controlled at 40-60 g / L before 72 hours; from 72 to 96 hours, the sugar concentration is controlled at 10-20 g / L, and the fermentation is terminated after 96 hours of culture.

[0044] In some embodiments, pH is adjusted using aqueous ammonia and / or calcium carbonate, and malic acid.

[0045] In some embodiments, the pH is regulated using ammonia and malic acid. In some embodiments, the pH is regulated using calcium carbonate and malic acid.

[0046] In some embodiments, pH is adjusted using aqueous ammonia and calcium carbonate, and malic acid.

[0047] In some embodiments, during the fermentation period of 0-48 hours, the pH is regulated by aqueous ammonia and malic acid; after 48 hours of fermentation, the pH is regulated by calcium carbonate and malic acid.

[0048] Beneficial Effects

[0049] The present invention replaces the brewer's yeast cell wall breaking liquid with yeast extract powder, and uses calcium carbonate to adjust the pH of the Schizochytrium fermentation liquid as an innovation. The brewer's yeast cell wall breaking liquid contains rich B vitamins, multiple vitamins, minerals, up to 50% or more protein, and contains a complete amino acid group. It is the best source for supplementing high-quality protein, so it is often used as a nitrogen source. However, the technical solution of using brewer's yeast cell wall breaking liquid in the present invention solves the problem of how to increase the dry weight, total fat, DHA content and sn-2DHA ratio of the fermentation liquid. In particular, it was unexpectedly found that using carbonates such as calcium carbonate and sodium carbonate as buffers to adjust the pH value of the fermentation liquid can further provide a preferred solution to these technical problems.

[0050] Terminology

[0051] Certain embodiments of the present invention are now described in detail. The present invention is intended to cover all substitutions, modifications and equivalent technical solutions, which are all included in the scope of the present invention as defined in the claims. It should be appreciated by those skilled in the art that many methods and materials similar or equivalent to those described herein can be used to practice the present invention. The present invention is by no means limited to the methods and materials described herein. In the event that one or more of the combined documents, patents and similar materials are different from or contradictory to the present application (including but not limited to defined terms, term applications, described technologies, etc.), the present application shall prevail.

[0052] It should be further appreciated that certain features of the invention, which for clarity are described in multiple separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which for brevity are described in a single embodiment, may also be provided separately or in any suitable sub-combination.

[0053] Unless otherwise specified, all technical terms used in the present invention have the same meaning as commonly understood by those skilled in the art to which the present invention belongs. All patents and publications related to the present invention are incorporated herein by reference in their entirety.

[0054] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example", or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, without contradiction.

[0055] In the following, all numbers disclosed herein are approximate, regardless of whether the word "about" or "approximately" is used. The value of each number may vary by 1%, 2%, 5%, 7%, 8%, 10%, 15% or 20%. Whenever a number with a value of N is disclosed, any number with a value of N+ / -1%, N+ / -2%, N+ / -3%, N+ / -5%, N+ / -7%, N+ / -8%, N+ / -10%, N+ / -15% or N+ / -20% will be explicitly disclosed, where "+ / -" means plus or minus.

[0056] Beer yeast cell wall breaking liquid: obtained by breaking the cell wall of beer yeast. In the present invention, the specific preparation method is to weigh 5kg of fresh beer yeast, wash and centrifuge it three times, then add a certain amount of water so that the volume ratio of the material to the liquid is 1:10; use sodium hydroxide and hydrochloric acid to adjust the pH value to 6.0, and heat the material to 55°C, then add 50g of alkaline protease and 5g of β-glucanase, continue stirring and hydrolyzing for 18-24h, during which the pH is stabilized at about 6.0. After the enzymolysis is completed, the temperature is raised to 85-95°C, and the enzyme is inactivated for 10-15min to obtain the beer yeast cell wall breaking liquid.

[0057] In the present invention, the concentration of ammonia water ranges from 5% to 30%. In some embodiments, the concentration of ammonia water ranges from 10% to 25%. In some embodiments, the concentration of ammonia water ranges from 20% to 25%.

[0058] Defoaming agent is an additive for eliminating foam. The defoaming agent used in the present invention is a defoaming agent suitable for the field of biological fermentation.

[0059] The dry weight and oil content of the fermentation liquid were determined by referring to the detection methods in the literature “Study on Fermentation Technology of High-yield DHA by Schizochytrium and Analysis of Its Metabolic Mechanism”.

[0060] The DHA content was determined using the internal standard method in GB 5009.168-2016.

[0061] The sn-2DHA content adopts the detection method in GB / T 24894-2010. DETAILED DESCRIPTION

[0062] In order to make the purpose, technical scheme and advantages of the present invention clearer, the present invention is further described in detail below in conjunction with embodiments. The specific embodiments described herein are only used to explain the present invention and are not intended to constitute any limitation of the present invention. In addition, in the following description, the description of known structures and technologies is omitted to avoid unnecessary confusion of the concepts of the present disclosure. Such structures and technologies are also described in many publications.

[0063] The reagents used in the present invention can be purchased from the market or prepared by the method described in the present invention.

[0064] Cultivation method:

[0065] (1) Primary seed tank culture: The Schizochytrium seeds were inoculated into the primary culture medium with an inoculation amount of 2.5%, an initial glucose of 60 g / L, a temperature of 25°C, a dissolved oxygen of more than 30%, a pH of 5.5-6.0, and a residual sugar of less than 20 g / L, and then inoculated into the secondary seed tank for about 24 hours.

[0066] (2) Secondary seed tank culture: inoculation amount is 10%, initial glucose is 60g / L, temperature is controlled at 25°C, dissolved oxygen is controlled to be greater than 30%, pH is 5.5-6.0, residual sugar is less than 20g / L and inoculated into the fermentation tank for about 13-16 hours.

[0067] (3) Fermentation tank culture: The pH of the fermentation tank culture is controlled at 5.0-6.5, and the dissolved oxygen is controlled at 40%-70% by adjusting the ventilation volume and the rotation speed. The sugar concentration is controlled at 40-60 g / L before 72 hours. From 72 to 96 hours, the sugar concentration is controlled at 10-20 g / L. The fermentation is terminated after 96 hours of culture, and the results are tested.

[0068] In some embodiments, the seed tank culture medium is: 50-80 g / L glucose, 10-20 g / L yeast powder, 10-25 g / L anhydrous sodium sulfate, 0.3-1.0 g / L potassium chloride, 2.0-6.0 g / L magnesium sulfate heptahydrate, 0.5-1.5 g / L potassium sulfate, 0.5-1.5 g / L potassium dihydrogen phosphate, 1.0-3.0 g / L ammonium sulfate and 0.1-0.3 g / L anhydrous calcium chloride, and the pH value is natural, preferably pH 5.5-6.0.

[0069] In some embodiments, the fermentation tank culture medium is: glucose 55-80 g / L, brewer's yeast cell wall breaking liquid 10-30 g / L, ammonium sulfate 1.0-3.0 g / L, anhydrous sodium sulfate 11-19 g / L, anhydrous magnesium sulfate 2.0-6.0 g / L, potassium sulfate 0.5-1.5 g / L, potassium dihydrogen phosphate 0.5-1.5 g / L, potassium chloride 0.3-1 g / L, anhydrous calcium chloride 0.1-0.3 g / L, vitamin B1 0.5-2.0 mg / L, vitamin B5 2-6 mg / L, vitamin B2 2-6 mg / L, vitamin B6 0.01-0.05 mg / L, vitamin B 12 0.2~0.6mg / L.

[0070] In some embodiments, the fermentation tank culture medium is: glucose 55-80 g / L, yeast powder 10-30 g / L, brewer's yeast cell wall breaking liquid 10-30 g / L, ammonium sulfate 1.0-3.0 g / L, anhydrous sodium sulfate 11-19 g / L, anhydrous magnesium sulfate 2.0-6.0 g / L, potassium sulfate 0.5-1.5 g / L, potassium dihydrogen phosphate 0.5-1.5 g / L, potassium chloride 0.3-1 g / L, anhydrous calcium chloride 0.1-0.3 g / L, vitamin B1 0.5-2.0 mg / L, vitamin B5 2-6 mg / L, vitamin B2 2-6 mg / L, vitamin B6 0.01-0.05 mg / L, vitamin B 12 0.2~0.6mg / L.

[0071] In some embodiments, the fermentation tank culture medium formula: glucose 60g / L, brewer's yeast cell wall breaking liquid 15-25g / L, anhydrous sodium sulfate 15g / L, anhydrous magnesium sulfate 4.1g / L, potassium dihydrogen phosphate 1.0g / L, potassium sulfate 1.0g / L, ammonium sulfate 0.17g / L, potassium chloride 0.5g / L, anhydrous calcium chloride 0.17g / L, vitamin B11 mg / L, vitamin B53 mg / L, vitamin B2, vitamin B60.01 mg / L, vitamin B 12 0.4 mg / L.

[0072] In some embodiments, the pH adjuster used in the fermentation tank culture medium may be aqueous ammonia, sodium hydroxide, sodium carbonate, sodium bicarbonate, calcium carbonate; citric acid, malic acid, acetic acid, propionic acid, hydrochloric acid, sulfuric acid.

[0073] In some embodiments, the pH adjuster used in the fermentation tank medium is aqueous ammonia, sodium carbonate, sodium bicarbonate, calcium carbonate, citric acid, or malic acid.

[0074] In some embodiments, the pH adjuster used in the fermentation medium is aqueous ammonia, calcium carbonate, or malic acid.

[0075] Seed cultivation

[0076] (1) Primary seed tank culture: The Schizochytrium seeds were inoculated into the primary culture medium with an inoculation amount of 2.5%, an initial glucose of 60 g / L, a temperature of 25°C, a dissolved oxygen of more than 30%, a pH of 5.5-6.0, and a residual sugar of less than 20 g / L, and then inoculated into the secondary seed tank for about 24 hours.

[0077] (2) Secondary seed tank culture: inoculation amount is 10%, initial glucose is 60g / L, temperature is controlled at 25°C, dissolved oxygen is controlled to be greater than 30%, pH is 5.5-6.0, residual sugar is less than 20g / L and inoculated into the fermentation tank for about 13-16 hours.

[0078] The composition of the seed tank culture medium: glucose 60g / L, yeast powder 10g / L, anhydrous sodium sulfate 15g / L, potassium chloride 0.5g / L, magnesium sulfate heptahydrate 4.1g / L, potassium sulfate 0.65g / L, potassium dihydrogen phosphate 1.0g / L, ammonium sulfate 1.0g / L and anhydrous calcium chloride 0.17g / L, the pH value is natural (i.e., no additional pH adjuster is added).

[0079] Fermentation tank culture

[0080] Example 1

[0081] 80 cubic fermentation tank: inoculation volume is 10%. By adjusting the ventilation volume and rotation speed, the dissolved oxygen is controlled at 40%-70%. The sugar concentration is controlled at 40-60g / L before 72h. From 72 to 96h, the sugar concentration is controlled at 10-20g / L, and the fermentation is terminated after 96h of cultivation. The fermentation pH is controlled at 5.0-6.5, and the pH is adjusted with ammonia water and 2.0g / L of L-malic acid.

[0082] Fermentation medium: glucose 60g / L, yeast powder 20g / L, ammonium sulfate 1.5g / L, anhydrous sodium sulfate 15g / L, anhydrous magnesium sulfate 2.0g / L, potassium sulfate 0.7g / L, potassium dihydrogen phosphate 1.0g / L, potassium chloride 0.5g / L, anhydrous calcium chloride 0.18g / L, vitamin B11 mg / L, vitamin B53 mg / L, vitamin B23 mg / L, vitamin B60.01 mg / L, vitamin B 12 0.4mg / L. Add 30mL / L of defoamer during fermentation.

[0083] Fermentation results: The dry weight of the fermentation liquid was 84.5 g / L, the total oil content was 463 mg / g, the DHA content was 219.3 mg / g, and the sn-2DHA accounted for 26.92% of the total DHA.

[0084] Example 2

[0085] 80 cubic fermentation tank: inoculation volume is 10%. By adjusting the ventilation volume and rotation speed, the dissolved oxygen is controlled at 40%-70%. The sugar concentration is controlled at 40-60g / L before 72h. From 72 to 96h, the sugar concentration is controlled at 10-20g / L, and the fermentation is terminated after 96h of cultivation. The fermentation pH is controlled at 5.0-6.5, and the pH is adjusted with ammonia water and 2.0g / L of L-malic acid.

[0086] Fermentation medium: glucose 60g / L, brewer's yeast cell wall breaking liquid 15g / L, ammonium sulfate 1.5g / L, anhydrous sodium sulfate 15g / L, anhydrous magnesium sulfate 2.0g / L, potassium sulfate 0.7g / L, potassium dihydrogen phosphate 1.0g / L, potassium chloride 0.5g / L, anhydrous calcium chloride 0.18g / L, vitamin B11 mg / L, vitamin B53 mg / L, vitamin B23 mg / L, vitamin B60.01 mg / L, vitamin B 12 0.4mg / L. Add 30mL / L of defoamer during fermentation.

[0087] Fermentation results: The dry weight of the fermentation liquid was 199g / L, the total oil content was 676mg / g, the DHA content was 336mg / g, the proportion of DHA to the total oil was 49.70%, and the proportion of sn-2DHA to the total DHA was 31.4%.

[0088] Example 3

[0089] 80 cubic fermentation tank: inoculation volume is 10%. By adjusting the ventilation volume and rotation speed, the dissolved oxygen is controlled at 40%-70%. The sugar concentration is controlled at 40-60g / L before 72h. From 72 to 96h, the sugar concentration is controlled at 10-20g / L, and the fermentation is terminated after 96h of cultivation. The fermentation pH is controlled at 5.0-6.5. From 0 to 48h, ammonia water and L-malic acid 2.0g / L are used to adjust the pH. After 48h of fermentation, calcium carbonate 4.0g / L and L-malic acid are used to adjust the pH.

[0090] Experimental group 3-1 was supplemented with 700 L of ammonia water; 0 to 48 h before, ammonia water was added when the pH dropped, and after the amount of ammonia water reached 700 L, calcium carbonate was used instead, and malic acid was used to adjust the pH throughout the process of rising.

[0091] Experimental group 3-2 was supplemented with 1500 L of ammonia water; 0 to 48 h before, ammonia water was added when the pH dropped, and after the amount of ammonia water reached 1500 L, calcium carbonate was used instead, and malic acid was used to adjust the pH throughout the process of rising.

[0092] Experimental group 3-3 was supplemented with 3000 L of ammonia water. Before 0-48 h, ammonia water was added when the pH dropped. After the amount of ammonia water reached 3000 L, calcium carbonate was used instead. Malic acid was used to adjust the pH throughout the process.

[0093] The fermentation was terminated after the culture was continued for 96 h.

[0094] Fermentation medium: glucose 60g / L, brewer's yeast cell wall breaking liquid 17g / L, ammonium sulfate 1.5g / L, anhydrous sodium sulfate 15g / L, anhydrous magnesium sulfate 2.0g / L, potassium sulfate 0.7g / L, potassium dihydrogen phosphate 1.0g / L, potassium chloride 0.5g / L, anhydrous calcium chloride 0.18g / L, vitamin B11 mg / L, vitamin B53 mg / L, vitamin B23 mg / L, vitamin B60.01 mg / L, vitamin B 12 0.4mg / L. Add 30mL / L of defoamer during fermentation.

[0095] Fermentation results:

[0096] Experimental group 3-1: the dry weight of the fermentation liquid was 188.9 g / L; the total oil content was 480 mg / g; the DHA content was 128.2 mg / g; the proportion of DHA in the total oil was 45.79%; the proportion of sn-2DHA in the total DHA was 41.0%.

[0097] Experimental group 3-2: the dry weight of the fermentation liquid was 207 g / L; the total oil content was 496 mg / g; the DHA content was 240.4 mg / g; the proportion of DHA in the total oil was 48.47%; the proportion of sn-2DHA in the total DHA was 43.4%.

[0098] Experimental group 3-3: the dry weight of the fermentation liquid was 204.3 g / L; the total oil content was 431 mg / g; the DHA content was 227.4 mg / g; the proportion of DHA in the total oil was 52.76%; the proportion of sn-2DHA in the total DHA was 44.8%.

[0099] Example 4

[0100] 80 cubic fermentation tank: inoculation volume is 10%. By adjusting the ventilation volume and rotation speed, the dissolved oxygen is controlled at 40%-70%. The sugar concentration is controlled at 40-60g / L before 72h. From 72 to 96h, the sugar concentration is controlled at 10-20g / L, and the fermentation is terminated after 96h of cultivation. The fermentation pH is controlled at 5.0-6.5, and the pH is adjusted by using 10.8g / L calcium carbonate and 2.0g / L L-malic acid.

[0101] Fermentation medium: glucose 60g / L, brewer's yeast cell wall breaking liquid 17g / L, ammonium sulfate 1.5g / L, anhydrous sodium sulfate 15g / L, anhydrous magnesium sulfate 2.0g / L, potassium sulfate 0.7g / L, potassium dihydrogen phosphate 1.0g / L, potassium chloride 0.5g / L, anhydrous calcium chloride 0.18g / L, vitamin B11 mg / L, vitamin B53 mg / L, vitamin B23 mg / L, vitamin B60.01 mg / L, vitamin B 12 0.4mg / L. Add 30mL / L of defoamer during fermentation.

[0102] Fermentation results: The dry weight of the fermentation liquid was 210.8 g / L, the total oil content was 715 mg / g, the DHA content was 379.7 mg / g, the proportion of DHA to total oil was 53.11%, and the proportion of sn-2DHA to total DHA was 52.79%.

[0103] As can be seen from the above, in Example 2, compared with Example 1, the brewer's yeast cell wall-breaking liquid was replaced with yeast extract powder, which significantly increased the dry weight of the fermentation liquid, total fat, DHA production, and the proportion of sn-2DHA in the total DHA. Example 3 supplemented ammonia water. As the amount of ammonia water added increased, all indicators increased. The overall dry weight of the fermentation liquid, total fat, DHA production, and the proportion of sn-2DHA in the total DHA were also higher than those in Example 1. In Example 4, the pH was adjusted with calcium carbonate and malic acid during the fermentation period, and the total fat, DHA content, and the proportion of sn-2DHA in the total DHA in the fermentation liquid were significantly improved compared with Examples 1, 2, and 3.

[0104] The present invention replaces the brewer's yeast cell wall breaking liquid with yeast extract powder, and uses calcium carbonate to adjust the pH of the Schizochytrium fermentation liquid as an innovation. The brewer's yeast cell wall breaking liquid contains rich B vitamins, multiple vitamins, minerals, up to 50% or more protein, and contains a complete amino acid group. It is the best source for supplementing high-quality protein, so it is often used as a nitrogen source. However, the technical solution of using brewer's yeast cell wall breaking liquid in the present invention solves the problem of how to increase the dry weight, total fat, DHA content and sn-2DHA ratio of the fermentation liquid. In particular, it was unexpectedly found that using carbonates such as calcium carbonate and sodium carbonate as buffers to adjust the pH value of the fermentation liquid can further provide a preferred solution to these technical problems.

[0105] In addition, carbonates are inexpensive, have no toxic side effects, and can be precipitated and recycled through some means, which can save production costs.

[0106] The method of the present invention has been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the methods and applications described herein within the content, spirit and scope of the present invention to implement and apply the technology of the present invention. Those skilled in the art can refer to the content of this article and appropriately improve the process parameters. It is particularly important to point out that all similar replacements and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention.

Claims

1. A fermentation method for improving the production of high DHA content and high sn-2DHA ratio by Schizochytrium schizochytrium fermentation, characterized in that: The method comprises the following steps: (1) Primary seed tank culture: inoculation amount is 2-5%; pH is controlled at 5.5-6.0, and residual sugar is less than 20 g / L before inoculation into the secondary seed tank; (2) Secondary seed tank culture: inoculation amount is 8-15%; pH is controlled at 5.5-6.0, and residual sugar is less than 20 g / L before inoculation into the fermentation tank; (3) Fermentation tank culture: pH is controlled at 5.0-6.5, sugar concentration is controlled at 40-60 g / L before 72 hours; from 72 to 96 hours, sugar concentration is controlled at 10-20 g / L; The culture medium includes a brewer's yeast cell wall breaking liquid; the brewer's yeast cell wall breaking liquid has a concentration of 15-25 g / L; the brewer's yeast cell wall breaking liquid preparation method includes: brewer's yeast and water are mixed at a material-liquid volume ratio of 1:10, the pH value is adjusted to 5.5-6.5, and hydrolyzed at 50-60° C. for 18-24 h using protease and β-glucanase; after enzymolysis, the temperature is raised to inactivate the enzyme to obtain the brewer's yeast cell wall breaking liquid; The culture medium also includes a carbon source, inorganic salts, and vitamins; The carbon source includes: one or more of glucose, corn syrup, glycerol, and sucrose; the concentration of the carbon source is 50-80 g / L; The inorganic salts include: one or more combinations of anhydrous sodium sulfate, anhydrous magnesium sulfate, potassium sulfate, potassium dihydrogen phosphate, potassium chloride and anhydrous calcium chloride; anhydrous sodium sulfate 11-19 g / L, anhydrous magnesium sulfate 2.0-6.0 g / L, potassium sulfate 0.5-1.5 g / L, potassium dihydrogen phosphate 0.5-1.5 g / L, potassium chloride 0.3-1 g / L, anhydrous calcium chloride 0.1-0.3 g / L; The vitamins include: vitamin B1, vitamin B5, vitamin B2, vitamin B6 and vitamin B 12 One or more combinations thereof; the vitamins include: vitamin B1 0.5-2.0 mg / L, vitamin B5 2-6 mg / L, vitamin B22-6 mg / L, vitamin B6 0.01-0.05 mg / L, vitamin B 12 0.2~0.6 mg / L; The culture medium also includes a nitrogen source; The nitrogen source is selected from one or more of yeast powder, corn steep liquor powder, and ammonium sulfate; the concentration of the nitrogen source is 1-20 g / L; During fermentation hours 0-48, pH was regulated by ammonia and malic acid; after 48 hours of fermentation, pH was regulated by calcium carbonate and malic acid.

2. The fermentation method according to claim 1, characterized in that The method comprises the following steps: (1) Primary seed tank culture: Inoculate Schizochytrium seeds into the primary culture medium with an inoculation rate of 2.5%; initial glucose 60 g / L, temperature controlled at 25 °C, dissolved oxygen controlled at more than 30%, pH 5.5-6.0, and residual sugar less than 20 g / L before inoculation into the secondary seed tank; (2) Secondary seed tank culture: inoculation amount is 10%; initial glucose is 60 g / L, temperature is controlled at 25°C, dissolved oxygen is controlled to be greater than 30%, pH is 5.5-6.0, and residual sugar is less than 20 g / L before inoculation into the fermentation tank; (3) Fermentation tank culture: The pH of the fermentation tank culture was controlled at 5.0-6.5, and the dissolved oxygen was controlled at 40%-70% by adjusting the ventilation volume and rotation speed; the sugar concentration was controlled at 40-60 g / L before 72 h; from 72 to 96 h, the sugar concentration was controlled at 10-20 g / L, and the fermentation was terminated after 96 h of culture.

Citation Information

Patent Citations

  • Method for producing DHA by Schizochytrium in high-density culture through fermentation

    CN101812484A

  • Method for producing DHA through Crypthecodinium cohnii fermentation

    CN103966273A

  • Production method of omega-3 polyunsaturated fatty acid

    CN116479063A

Cited By

  • Algal oil fermentation method for increasing sn-2 DHA (docosahexaenoic acid) proportion

    CN121674498A